Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 798 results for "lymphocyte count"

Circulating neutrophil, monocyte, lymphocyte counts predict su...

Both high pretreatment circulating neutrophil and monocyte counts independently predicted shorter OS and RFS among patients with HPV-positive oropharyngeal cancers, according to study results. High circulating lymphocyte counts predicted improved ... Orthopedics Today, 3 weeks ago

MS Drug May Trigger Lymphopenia in Slim Women (CME/CE)

Action Points Note that this cohort study of patients receiving fingolimod found that low lymphocyte count and low BMI were associated with a greater risk of lymphopenia. Be aware that the sample size of this study was too small to robustly ...
 MedPage Today4 weeks ago Fingolimod (Gilenya) and lymphopenia risk  Multiple Sclerosis Trust3 weeks ago

Safety and Immunogenicity of H1/IC31®, an Adjuvanted TB Subunit Vaccine, in HIV-Infected Adults with CD4+ Lymphocyte Counts Greater than 350 cells/mm3: A Phase II, Multi-Centre, Double-Blind, Randomized, Placebo-Controlled Trial

by Klaus Reither, Lynn Katsoulis, Trevor Beattie, Nicolene Gardiner, Nicole Lenz, Khadija Said, Elirehema Mfinanga, Christian Pohl, Katherine L. Fielding, Hannah Jeffery, Benjamin M. Kagina, Elisabeth J. Hughes, Thomas J. Scriba, Willem A. Hanekom, ...
 Plosone.org1 month ago
Monthly Prescribing Reference

FDA Approves Genentech's Combination Leukemia Treatment

When used in combination with chlorambucil to treat chronic lymphocytic leukemia, Gazyva was found to be more effective than Rituxan. Genentech has received FDA approval for a supplemental biologics license application (sBLA) for Gazyva ...
 PharmTech.com3 weeks ago FDA Updates Gazyva Label for Frontline Chronic Lymphocytic Leukemia  CURE Magazine4 weeks ago Genentech: FDA Okays Gazyva SBLA With New Data In Chronic Lymphocytic Leukemia  RTTNews.com1 month ago FDA Approves Gazyva® (Obinutuzumab) Supplemental Biologics License Application with New Data in Previously Untreated Chronic Lymphocytic Leukemia  CancerConnect.com1 week ago

Arena Pharma: APD334 Shows Dose-dependent Lymphocyte Lowering In Phase 1b Trial

Arena Pharmaceuticals, Inc. (ARNA: Quote) announced top-line results from a Phase 1b multiple ascending dose clinical trial for APD334, an oral drug candidate that targets the sphingosine 1-phosphate subtype 1 or S1P1 receptor for the potential ...
 RTTNews.com2 weeks ago Arena Pharmaceuticals Reports Positive Results from Phase 1b Clinical Trial Evaluating APD334 for the Treatment of Autoimmune Diseases  Review Seeker2 weeks ago Arena announces positive results from Phase Ib autoimmune disease trial  Individual.com1 week ago Arena's APD334 Has Real Blockbuster Potential  Seeking Alpha2 weeks ago

Tumor-Infiltrating Lymphocytes and Response to Platinum in Triple-Negative Breast Cancer [Editorials]

2015 by American Society of Clinical Oncology Nadine M. Tung ⇑ Beth Israel Deaconess Medical Center, Boston, MA Corresponding author: Nadine M. Tung, MD, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, ...
 Journal of Clinical Oncology2 weeks ago

Hemophagocytic Lymphohistiocytosis With Cerebral Involvement in Richter's Syndrome [Diagnosis in Oncology]

A 69-year-old man presented with a several week history of progressive cerebellar ataxia and myoclonia. His past medical history included hypertension and a resected prostatic neoplasm, considered to be in remission. Except for the neurologic ...
 Journal of Clinical Oncology1 month ago

Immune modulation in acute ischemic stroke [Medical Sciences]

Peripheral lymphocytes entering brain ischemic regions orchestrate inflammatory responses, catalyze tissue death, and worsen clinical outcomes of acute ischemic stroke (AIS) in preclinical studies. However, it is not known whether modulating brain ...
 PNAS1 month ago
Fred Hutch

RIT-NMAT: A new hope for high-risk lymphoma patients

Kaplan-Meier curves of progression-free survival (PFS) and overall survival (OS) in the control and radioimmunotherapy (RIT) groups. The solid lines represent the observed outcomes and the dashed lines represent estimates adjusted with regard to the ...
 Fred Hutch4 days ago IMBRUVICA® (ibrutinib) Long-term Follow-up Data in Patients Living with Relapsed/Refractory Mantle Cell Lymphoma Show Almost Half Alive at Two Years  TickerTech.com1 month ago IMBRUVICA® (ibrutinib) Shows Sustained Progression-Free Survival in Patients with High-Risk Chronic Lymphocytic Leukemia with Genetic Mutation  Wall Street Business Network1 month ago J&J -IMBRUVICA (ibrutinib) Shows Sustained Progression-Free Survival in Patients with High-Risk Chronic Lymphocytic Leukemia with Genetic Mutation  Pharmacy Choice1 month ago

REVLIMID® (Lenalidomide) Single-Agent and Combination Studies in Mantle Cell Lymphoma (MCL) Presented at ASH

Celgene Corporation ( NASDAQ:CELG ) today announced results from studies of REVLIMID ® (lenalidomide) and the combination of lenalidomide plus rituximab in patients with mantle cell lymphoma (MCL), which were presented during ...
 Franklin Credit Management Corporation1 month ago Celgene Release: REVLIMID® (Lenalidomide) Single-Agent And Combination Studies In Mantle Cell Lymphoma (MCL) Presented At American Society of Hematology  BioSpace1 month ago Combination of ISTODAX® (romidepsin) and Standard CHOP Demonstrates a Complete Response in 51% of Patients with Peripheral T-Cell Lymphoma  Morningstar.com1 month ago REVLIMID(R) (Lenalidomide) Single-Agent and Combination Studies in Mantle Cell Lymphoma (MCL) Presented at ASH  Scottrade1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less